Moulay A. Alaoui-Jamali
Affiliations: | McGill University, Montreal, QC, Canada |
Area:
Molecular Biology, Oncology, Microbiology BiologyGoogle:
"Moulay Alaoui-Jamali"Children
Sign in to add trainee| Iris J. Groisman | grad student | 2001 | McGill |
| Daniela Marcantonio | grad student | 2001 | McGill |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| de Lima JM, Morand GB, Macedo CCS, et al. (2020) Ndrg1 Deficiency is associated with Regional Metastasis in Oral Cancer by inducing Epithelial-Mesenchymal transition. Carcinogenesis |
| Sirois I, Aguilar-Mahecha A, Lafleur J, et al. (2019) A unique morphological phenotype in chemoresistant triple negative breast cancer reveals metabolic reprogramming and PLIN4 expression as a molecular vulnerability. Molecular Cancer Research : McR |
| Shorstova T, Marques M, Su J, et al. (2019) SWI/SNF-compromised cancers are susceptible to bromodomain inhibitors. Cancer Research |
| Chang CH, Bijian K, Wernic D, et al. (2019) A novel orally available seleno-purine molecule suppresses triple-negative breast cancer cell proliferation and progression to metastasis by inducing cytostatic autophagy. Autophagy |
| Guo Q, Li VZ, Nichol JN, et al. (2019) MNK1/NODAL signaling promotes invasive progression of breast ductal carcinoma in situ. Cancer Research |
| Marques M, Jangal M, Wang LC, et al. (2018) Oncogenic activity of poly (ADP-ribose) glycohydrolase. Oncogene |
| Daniela da Silva S, Xu B, Maschietto M, et al. (2018) TRAF2 COOPERATES WITH FOCAL ADHESION SIGNALING TO REGULATE CANCER CELL SUSCEPTIBILITY TO ANOIKIS. Molecular Cancer Therapeutics |
| Li L, Guturi KKN, Gautreau B, et al. (2018) Ubiquitin ligase RNF8 suppresses Notch signaling to regulate mammary development and tumorigenesis. The Journal of Clinical Investigation |
| Carnielli CM, Macedo CCS, De Rossi T, et al. (2018) Combining discovery and targeted proteomics reveals a prognostic signature in oral cancer. Nature Communications. 9: 3598 |
| Ghashghaei M, Muanza T, Alaoui-Jamali M, et al. (2018) Abstract 858: Enzalutamide versus abiraterone as a radiosensitizer in hormone-sensitive prostate cancer cells Cancer Research. 78: 858-858 |